| scholarly article | Q13442814 |
| P50 | author | Enmoore Lin | Q61278582 |
| Louis Schofield | Q80331838 | ||
| Danielle I Stanisic | Q86061713 | ||
| Leanne J Robinson | Q88893986 | ||
| Peter M Siba | Q89223280 | ||
| Benson Kiniboro | Q114307173 | ||
| Sarah Javati | Q117223968 | ||
| Peter A. Zimmerman | Q39408524 | ||
| Ingrid Felger | Q39408549 | ||
| Freya Fowkes | Q42800053 | ||
| James Beeson | Q56780488 | ||
| James W Kazura | Q56781816 | ||
| Ivo Mueller | Q60043791 | ||
| P2093 | author name string | Christopher L King | |
| Jack S Richards | |||
| Melanie Koinari | |||
| P2860 | cites work | Congenital malaria | Q75685132 |
| Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti | Q24810344 | ||
| Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea | Q28744515 | ||
| Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria | Q31169310 | ||
| Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum | Q33380204 | ||
| Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults | Q33380213 | ||
| Rapid assessment of malaria transmission using age-specific sero-conversion rates | Q33475618 | ||
| The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria | Q33512926 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children | Q33530114 | ||
| Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies | Q33548663 | ||
| Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure | Q33935818 | ||
| Specificity of the protective antibody response to apical membrane antigen 1 | Q34007362 | ||
| Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli | Q34122492 | ||
| Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria | Q34301187 | ||
| Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea | Q34421706 | ||
| Research priorities for the development and implementation of serological tools for malaria surveillance | Q34500035 | ||
| The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody | Q34601904 | ||
| Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia | Q34720387 | ||
| Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans | Q34781485 | ||
| Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria | Q34827195 | ||
| Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children | Q35016669 | ||
| Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic | Q35016677 | ||
| Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum | Q35383761 | ||
| Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. | Q35505807 | ||
| Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria | Q35569042 | ||
| Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children | Q36056571 | ||
| Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies | Q36227228 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? | Q36391845 | ||
| Clinical immunity to malaria | Q36412877 | ||
| Humoral responses to plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. | Q36421572 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
| The risk of malarial infections and disease in Papua New Guinean children. | Q37088901 | ||
| Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
| A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria | Q37148056 | ||
| Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity | Q37202344 | ||
| Recent insights into humoral and cellular immune responses against malaria | Q37291684 | ||
| Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping | Q37415484 | ||
| The future for blood-stage vaccines against malaria | Q37471465 | ||
| Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda | Q38876186 | ||
| Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. | Q38998328 | ||
| Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity | Q39148311 | ||
| Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria | Q39247931 | ||
| High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya | Q39362550 | ||
| Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Q39417737 | ||
| Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum | Q39518517 | ||
| Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass | Q39823427 | ||
| Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals | Q40613128 | ||
| Adjusting for heterogeneity of malaria transmission in longitudinal studies | Q42577113 | ||
| Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes | Q42938913 | ||
| Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates | Q43952320 | ||
| Small-area variations in the epidemiology of malaria in Madang Province. | Q44808119 | ||
| Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. | Q46334562 | ||
| Action of Malarial Antibody in vitro | Q47680023 | ||
| IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. | Q47830190 | ||
| Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro | Q47845842 | ||
| Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region | Q47911253 | ||
| Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia | Q47954510 | ||
| Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria | Q47957417 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese vi | Q48000659 | ||
| Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. | Q48012112 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| antibody | Q79460 | ||
| Plasmodium falciparum | Q311383 | ||
| merozoite | Q2296434 | ||
| P304 | page(s) | 646-660 | |
| P577 | publication date | 2014-11-24 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response | |
| P478 | volume | 83 |
| Q62738219 | A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 E on blood stage immunity in young Kenyan children. |
| Q36555051 | Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand |
| Q56358597 | Antibodies to Intercellular Adhesion Molecule 1-Binding Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLβ Are Biomarkers of Protective Immunity to Malaria in a Cohort of Young Children from Papua New Guinea |
| Q92697512 | Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand |
| Q61447733 | Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Infections |
| Q33636850 | Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum |
| Q37202370 | Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period |
| Q64237708 | Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria |
| Q99709750 | Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia |
| Q92016834 | Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India |
| Q92734084 | Antigenicity and immune correlate assessment of seven Plasmodium falciparum antigens in a longitudinal infant cohort from northern Ghana |
| Q47347281 | Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII–V in Ghanaian children living in two communities with varying malaria transmission patterns |
| Q38680896 | Bayesian spatio-temporal modeling of mortality in relation to malaria incidence in Western Kenya |
| Q36071335 | Biosignatures of Exposure/Transmission and Immunity |
| Q37690056 | Burden of malaria in mobile populations in the Greater Accra region, Ghana: a cross- sectional study |
| Q59330088 | Characterization of anti-EBA175RIII-V in asymptomatic adults and children living in communities in the Greater Accra Region of Ghana with varying malaria transmission intensities |
| Q37031586 | Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination |
| Q36555103 | Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort |
| Q57462998 | Controlled infection immunization using delayed death drug treatment elicits protective immune responses to blood-stage malaria parasites |
| Q41991578 | Declining malaria transmission differentially impacts on the maintenance of humoral immunity to Plasmodium falciparum in children |
| Q33874236 | Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children. |
| Q37597307 | Development of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area |
| Q38645943 | Dichotomous miR expression and immune responses following primary blood-stage malaria |
| Q64086742 | Differential Patterns of IgG Subclass Responses to Antigens in Relation to Malaria Protection and RTS,S Vaccination |
| Q39230991 | Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance |
| Q64114093 | Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe |
| Q94606197 | Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period |
| Q47179255 | Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana |
| Q46222698 | Evaluating anti-disease immunity to malaria and implications for vaccine design. |
| Q53698025 | Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains. |
| Q41994105 | Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development |
| Q45944502 | Identification of immune signatures predictive of clinical protection from malaria. |
| Q41956908 | IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children |
| Q89571059 | IgG antibody response against Plasmodium falciparum aminopeptidase 1 antigen in Gabonese children living in Makokou and Franceville |
| Q38689264 | Immunity to malaria in an era of declining malaria transmission |
| Q62486713 | Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure |
| Q38728598 | Insights into the naturally acquired immune response to Plasmodium vivax malaria |
| Q36251388 | Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya |
| Q91713619 | Molecular Characterization and Immuno-Reactivity Patterns of a Novel Plasmodium falciparum Armadillo-Type Repeat Protein, PfATRP |
| Q35961275 | Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities |
| Q40073901 | Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children. |
| Q36138015 | Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure |
| Q96303439 | Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria |
| Q92664225 | Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort |
| Q26315542 | Plasmodium malaria and antimalarial antibodies in the first year of life |
| Q37627098 | Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants. |
| Q28554358 | Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children |
| Q37118029 | Prenatal exposure to Plasmodium falciparum increases frequency and shortens time from birth to first clinical malaria episodes during the first two years of life: prospective birth cohort study |
| Q92574146 | Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination |
| Q61795950 | Reverse immunodynamics: a new method for identifying targets of protective immunity |
| Q37394822 | Serological markers to measure recent changes in malaria at population level in Cambodia |
| Q58567578 | Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1 subunit proteins in multiplexed serologic assays |
| Q36723862 | Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand |
| Q61446491 | The impact of early life exposure to Plasmodium falciparum on the development of naturally acquired immunity to malaria in young Malawian children |
| Q42364305 | Timing of the human prenatal antibody response to Plasmodium falciparum antigens |
| Q96431447 | Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria |
Search more.